Right Value Drug Stores Recalls Testosterone Pellets Due to Labeling Error
Right Value Drug Stores is recalling 4,800 Testosterone 200 mg Pellets because the label contains an incorrect expiration date.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The recall is classified as FDA Class III, which the rubric defines as typically resulting in a score of 1 or 2 because it is unlikely to cause adverse health consequences. The issue is a documentation/labeling error.
Plain-English summary
Right Value Drug Stores, Inc. is recalling 4,800 Testosterone 200 mg Pellets. The product is a prescription-only medication distributed nationwide in the United States. The specific lot number is 061918@08.
The recall was initiated due to a labeling error where the expiration date printed on the label is incorrect. The source text does not specify the correct expiration date or the nature of the discrepancy beyond it being incorrect.
Consumers who have this product should stop using it and contact their healthcare provider or the recalling firm for further instructions. The recall is classified as Class III by the FDA, indicating the product is not likely to cause adverse health consequences.
The recalled product
- Product
- Testosterone 200 mg Pellet, Rx only, Carie Boyd's Prescription Shop 122 Grapevine Hwy., Hurst, TX 76054, 800-930-4361
- Manufacturer
- Right Value Drug Stores, Inc.
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 4,800
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 061918@08
- Exp.11/28/2019
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Right Value Drug Stores, Inc.
See all →- LowRight Value Drug Stores Recalls Tadalafil SR 7 mg Capsules for Misbranding
FDA (Drugs) · 2018-11-21
- LowRight Value Drug Stores Recalls Progesterone SR 200 mg Capsules for Misbranding
FDA (Drugs) · 2018-11-21
- LowRight Value Drug Stores Recalls Tadalafil SR 12 mg Capsules for Misbranding
FDA (Drugs) · 2018-11-21
- LowRight Value Drug Stores Recalls Progesterone SR 100 mg Capsules for Misbranding
FDA (Drugs) · 2018-11-21
- ModerateRight Value Recalls Glutathione Injectable Due to Incorrect Gas Formulation
FDA (Drugs) · 2015-01-14
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02